About Beta-sarcoglycan
Beta-sarcoglycan (SGCB) is a protein
from Homo sapiens identified by UniProt accession
Q16585, 318 residues long.
MolForge cross-references it against 0 known binders and
491 disease associations.
Target properties
| Protein name | Beta-sarcoglycan |
| UniProt accession | Q16585 |
| Gene | SGCB |
| Organism | Homo sapiens |
| Length | 318 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (491)
Diseases linked to this target (Open Targets).
- autosomal recessive limb-girdle muscular dystrophy type 2E · score 0.81
- limb-girdle muscular dystrophy · score 0.67
- autosomal recessive limb-girdle muscular dystrophy · score 0.65
- qualitative or quantitative defects of beta-sarcoglycan · score 0.47
- genetic disorder · score 0.46
- Abnormality of the musculature · score 0.44
- dilated cardiomyopathy · score 0.38
- sialidosis · score 0.27
- platelet count · score 0.25
- neurodegenerative disease · score 0.21
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q16585-F1 | alphafold | PREDICTED | 76.42 | — |
Amino-acid sequence (318 residues)
MAAAAAAAAE QQSSNGPVKK SMREKAVERR SVNKEHNSNF KAGYIPIDED RLHKTGLRGR KGNLAICVII LLFILAVINL IITLVIWAVI RIGPNGCDSM EFHESGLLRF KQVSDMGVIH PLYKSTVGGR RNENLVITGN NQPIVFQQGT TKLSVENNKT SITSDIGMQF FDPRTQNILF STDYETHEFH LPSGVKSLNV QKASTERITS NATSDLNIKV DGRAIVRGNE GVFIMGKTIE FHMGGNMELK AENSIILNGS VMVSTTRLPS SSSGDQLGSG DWVRYKLCMC ADGTLFKVQV TSQNMGCQIS DNPCGNTH
Explore Beta-sarcoglycan with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets